|

UN Group to Debate Asbestos/Mesothelioma Link

UN

The link between chrysotile asbestos and illnesses such as mesothelioma will be high on the agenda when the sixth UN Rotterdam Convention meets in Geneva, Switzerland in late April.

The group, made up of representatives from around the world, will be considering whether or not chrysotile or white asbestos will finally be added to the list of Controlled Hazardous Substances. The Rotterdam Convention was assembled in 2002 with the goal of protecting people and the environment from toxic chemicals like asbestos. However, in order to include chrysotile asbestos on the list, the vote of all represented countries must be unanimous. In the past, countries that still export, import or use asbestos, including Canada, Brazil, Russia and India, have worked to keep chrysotile off the toxic list. India withdrew its objection in 2011, but Canada has held its ground.

A naturally-occurring mineral, asbestos was once highly prized as a strong, inexpensive and heat-resistant additive to insulation and many building products. But after medical studies linked it to mesothelioma, lung cancer and chronic illnesses like asbestosis, the use of asbestos dropped dramatically. Many countries have banned the substance. According to an article in The Lancet, chrysotile asbestos is the only type still produced and accounts for more than 95% of all asbestos mined.

Despite the mesothelioma risk, Canada, Russia and several other countries continue to maintain multi-billion dollar asbestos industries, selling it primarily to underdeveloped countries such as Bangladesh where regulations may be lax or nonexistent. Not surprisingly, the rates of mesothelioma in and around asbestos mining towns are dramatically higher than other parts of the world. Mesothelioma is usually an extremely rare cancer, making up a tiny fraction of all cancer cases. But in places where asbestos dust is prevalent – such as Libby, Montana, home of a former U.S. asbestos mine – mesothelioma rates can be hundreds of times higher than in the general population.

Mesothelioma occurs when inhaled or ingested asbestos fibers lodge in the tissue, setting up chronic irritation and inflammation at the cellular level. Over time, this inflammatory response can lead to DNA damage and eventually mesothelioma. Mesothelioma grows on the membranes that line the heart, lungs or abdomen.

Although news reports in advance of the Rotterdam Convention, which runs from April 28 to May 10, suggest that Canada may finally stop opposing chrysotile’s addition to the toxic list, several other major players still oppose it.   Worldwide, the World Health Organization reports that 90,000 people a year die of asbestos-related diseases which includes mesothelioma and asbestosis. In a joint statement released in February, the WHO and the International Agency for Research on Cancer stated that all forms of asbestos are carcinogenic and called for an end to all uses of asbestos.

Sources:

Rotterdam Convention website, Chrysotile Asbestos page.
“Dissenting Industrialists Filibuster inclusion of Chrysotile in Rotterdam Treaty’s Repeated Appeal to Censure Asbestos, curtail Mesothelioma”, March 12, 2013, PR Web.
Holmes, David, “IARC in the dock over ties with asbestos industry”, February 2, 2013, The Lancet, pp. 359-361.

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…